Cytogenetics of the Viatica group of morabine grasshoppers II.Kangaroo Island populations
1969 · Australian Journal of Zoology · 39 citations
https://doi.org/10.1071/zo9690313
M
Marc André
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
165
Citations
8
h-index
6
i10-index
Marc André is an academic researcher from CHU Dinant Godinne UCL Namur. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Chronic Lymphocytic Leukemia Research & Viral-associated cancers and disorders. The author has an h-index of 8, co-authored 18 publications.
Papers by this author
worksIbrutinib plus venetoclax in relapsed or refractory mantle cell lymphoma (SYMPATICO): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
2025 · The Lancet Oncology · 24 citations
https://doi.org/10.1016/s1470-2045(24)00682-x
Thalidomide as an effective treatment for adult multiple xanthogranuloma
2018 · JAAD Case Reports · 9 citations
https://doi.org/10.1016/j.jdcr.2018.05.005
Camidanlumab tesirine for relapsed or refractory classic Hodgkin lymphoma: a phase 2 study
2025 · Blood Advances · 3 citations
https://doi.org/10.1182/bloodadvances.2024015600
Efficacy and Safety of Ibrutinib Plus Venetoclax in Patients With Mantle Cell Lymphoma (MCL) and TP53 Mutations in the SYMPATICO Study
2024 · Clinical Lymphoma Myeloma & Leukemia · 1 citations
https://doi.org/10.1016/s2152-2650(24)00886-3
MCL-058 Efficacy and Safety of Ibrutinib Plus Venetoclax in Patients With Mantle Cell Lymphoma (MCL) and TP53 Mutations in the SYMPATICO Study
2024 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(24)01592-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat